Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening
NCT ID: NCT06100250
Last Updated: 2025-07-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2024-04-19
2025-03-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Internet-based HIV/STI Prevention for Young MSM Receiving HIV Testing
NCT00968188
Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP"
NCT05528653
Peer Delivered HIV/Syphilis Self-Testing With Assisted Partner Notification Services
NCT06791928
Bacterial Sexually Transmitted Infections (STIs) Viability by Polymerase Chain Reaction (PCR)
NCT05959408
Effectiveness of an Online Prevention Program in Reducing the Risk of STD Infection in Young Adults
NCT00255944
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telehealth intervention
Participants will receive an MI-based telehealth intervention for bacterial STI screening.
Motivational interviewing and specimen self-collection
Participants will be asked to attend a pre-test live AV conferencing session, collect and return a urine sample, a throat swab, a rectal swab, and a blood sample for bacterial STI testing, and attend a post-test live AV conferencing session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motivational interviewing and specimen self-collection
Participants will be asked to attend a pre-test live AV conferencing session, collect and return a urine sample, a throat swab, a rectal swab, and a blood sample for bacterial STI testing, and attend a post-test live AV conferencing session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individual self-reports residing in a US state or territory in the eligibility screener
* Individual self-reports being physically located in a US state or territory when completing study activities in the eligibility screener
* Individual self-reports being greater than or equal to (≥)18 years of age in the eligibility screener
* Individual self-reports being of legal age to provide consent for research participation in the US state or territory of residence in the eligibility screener
* Individual self-reports having been diagnosed with HIV in the eligibility screener
* Individual self-reports having any kind of condomless sex (e.g., oral, anal) with ≥2 men in the past year in the eligibility screener
* Individual self-reports being willing to provide contact information (full name, email address, mobile phone number, and mailing address) in the eligibility screener
* Individual self-reports being able to participate in live AV conferencing sessions using an internet-connected device (e.g., computer, tablet, smartphone) in the eligibility screener
* Individual self-reports being willing to receive a box that contains kits to self-collect a urine sample, a throat swab, a rectal swab, and a blood sample for bacterial STI testing in the eligibility screener
* Individual provides valid contact information (full name, email address, mobile phone number, and mailing address) in the contact information form
* Individual completes the baseline survey in order to receive the intervention
Exclusion Criteria
* Individual self-reports not residing in a US state or territory in the eligibility screener
* Individual self-reports not being physically located in a US state or territory when completing study activities in the eligibility screener
* Individual self-reports not being ≥18 years of age in the eligibility screener
* Individual self-reports not being of legal age to provide consent for research participation in the US state or territory of residence in the eligibility screener
* Individual self-reports not having been diagnosed with HIV in the eligibility screener
* Individual self-reports not having any kind of condomless sex (e.g., oral, anal) with ≥2 men in the past year in the eligibility screener
* Individual self-reports not being willing to provide contact information (full name, email address, mobile phone number, and mailing address) in the eligibility screener
* Individual self-reports not being able to participate in live AV conferencing sessions using an internet-connected device (e.g., computer, tablet, smartphone) in the eligibility screener
* Individual self-reports not being willing to receive a box that contains kits to self-collect a urine sample, a throat swab, a rectal swab, and a blood sample for bacterial STI testing in the eligibility screener
* Individual does not provide valid contact information (full name, email address, mobile phone number, and mailing address) in the contact information form
* Individual does not complete the baseline survey in order to receive the intervention
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Akshay Sharma
Associate Professor, University of Michigan School of Nursing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Akshay Sharma, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sharma A, Boyd S, Bonar EE. Feasibility and Acceptability of a Motivational Interviewing-Based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening: Protocol for a Sequential Explanatory Mixed Methods Study. JMIR Res Protoc. 2024 Aug 29;13:e64433. doi: 10.2196/64433.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00240181
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.